Get startedLog in
    Picture of Torrent Pharmaceuticals logo

    TORNTPHARM — Torrent Pharmaceuticals Cashflow Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Torrent Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    R2020
    March 31st
    C2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSPRESS
    Standards:
    IAS
    IAS
    IAS
    IAS    		—
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line11,86615,26312,25918,47223,520
    Depreciation
    Non-Cash Items2,2183,3516,8782,3071,860
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-6,699-5,138-7,729-3,574-800
    Change in Accounts Receivable
    Change in Inventories
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities13,92920,05418,03024,27032,660
    Capital Expenditures-4,068-3,352-2,026-5,739-4,330
    Purchase of Fixed Assets
    Other Investing Cash Flow Items6,054-1,14359.4-18,4142,650
    Acquisition of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities1,986-4,494-1,966-24,153-1,680
    Financing Cash Flow Items-4,854-3,561-2,577-3,030-3,710
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-15,490-16,508-17,811774-27,790
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash731-893-1,7421,1013,270